<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="579">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347070</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0175</org_study_id>
    <nct_id>NCT04347070</nct_id>
  </id_info>
  <brief_title>Implementation of Physiotherapy on COVID-19 Patients in ICU</brief_title>
  <acronym>PHYSIO-COVID</acronym>
  <official_title>Implementation of Physiotherapy on COVID-19 Patients in Intensive Care Units : a Retrospective, Multicentric, International Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société espagnole de pneumologie (SEPAR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Societe française de kinésithérapie en réanimation (SKR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite new charachersitics of COVID-19 patients, critical care implementation seems to be
      similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units
      (ICU).

      Regarding the initial gravity of these patients, sedation and neuromuscular blockers are
      usually administrated, increasing the risk to develope an ICU-acquired weakness which is
      directly correlated to morbi-mortality and a burden during recovery.

      Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33%
      of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is
      only implemented in after case-by-case evaluation.

      This unprecedented situation requires to identify how physiotherapy is being implemented in
      COVID-19 patients in ICU.

      This retrospective, multicentric study aims to identify the charactheristics of physiotherapy
      (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Demographics data : hospitalisation date, ICU date, COVID+ date, extubation date,
           discharge date, mortality

        -  ICU data : ventilatory mode, type of physiotherapy implemented (early rehabilitation,
           chest physiotherapy, time spent (minutes), number of interventions per day.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time of physiotherapy</measure>
    <time_frame>1 day</time_frame>
    <description>Time of physiotherapy (minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of physiotherapy</measure>
    <time_frame>3 day</time_frame>
    <description>Time of physiotherapy (minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of physiotherapy</measure>
    <time_frame>7 day</time_frame>
    <description>Time of physiotherapy (minutes)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Type of physiotherapy implemented</measure>
    <time_frame>1 day</time_frame>
    <description>Type of physiotherapy , early rehabilitation or chest phsyitoherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of physiotherapy implemented</measure>
    <time_frame>3 day</time_frame>
    <description>Type of physiotherapy , early rehabilitation or chest phsyitoherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of physiotherapy implemented</measure>
    <time_frame>7 day</time_frame>
    <description>Type of physiotherapy , early rehabilitation or chest phsyitoherapy</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Sars-CoV2</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Patients accepted in ICU diagnosed with COVID-19</arm_group_label>
    <description>Patients accepted in ICU diagnosed with COVID-19</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phsyiotherapy</intervention_name>
    <description>To observe if patients with COVID-19 benefice of physiothersapy, which kind and how many time</description>
    <arm_group_label>Patients accepted in ICU diagnosed with COVID-19</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted in ICU with COVID-19 will be eligible
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age &gt; 18 years

          -  Patient admitted in ICU

          -  Patient with COVID-19 diagnosis

        Exclusion criteria:

        - Explicite denie to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Martinez-Alejos, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>roberto Martinez-Alejos, Physiotherapis</last_name>
    <phone>677952556</phone>
    <phone_ext>33</phone_ext>
    <email>r-martinezalejos@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gustavo Plotnikow, Physiotherapis</last_name>
    <phone>49116543771</phone>
    <phone_ext>33</phone_ext>
    <email>gplotnikow@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Martinez-Alejos</last_name>
      <email>r-martinezalejos@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Gustavo Plotnikow</last_name>
      <email>gplotnikow@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 10, 2020</study_first_submitted>
  <study_first_submitted_qc>April 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Physiotherapy</keyword>
  <keyword>implementation</keyword>
  <keyword>critical care</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

